Gene synthesis

#DNA technology #Gene synthesis #Gene therapy #Protein design

Cell-free DNA programme could ‘empower’ therapeutics to market

A newly accessible cell-free DNA programme could “empower” therapeutics to market, the CEO of Ribbon Bio has said. Jodi Barrientos, CEO of the synthetic biology company, was speaking at the ‘Engineering Biology: DNA and Beyond’ conference in Vienna, Austria, which took place on the 5 and 6 March. At the… Read More

#News

Artificial intelligence
#AI #Drug discovery #Gene synthesis #Synthetic biology

How AI is transforming gene synthesis and genome engineering 

Ajay Gannerkote, President, Integrated DNA Technologies examines how AI is helping to advance the drug discovery landscape. In the past decade, few fields in biotechnology have evolved as dramatically as gene synthesis and genome engineering.  The evolution of digital technologies, particularly the advent of artificial intelligence (AI), has resulted in a… Read More

#Exclusive Content

#Gene synthesis #Genetic medicines #Guide #Synthetic DNA

Guide: Next generation cell-free gene synthesis

Struggling to make sense of the strategies, technology and trade-offs when developing a DNA supply chain? Elegen has created a comprehensive overview of the evolving field of gene synthesis entitled ‘The Next-Gen DNA Buyers Guide: From design to results faster and more reliably with cell-free gene synthesis’. The Guide… Read More

#News

#Gene synthesis #Genetic medicines #Synthetic DNA

Next generation cell-free gene synthesis

Struggling to make sense of the strategies, technology and trade-offs when developing a DNA supply chain? Elegen created a comprehensive overview of the evolving field of gene synthesis. This Guide contains a detailed comparison of 10 industry-leading vendors, including key metrics such as error rate, turnaround time, cost, and maximum… Read More

#Intelligence #Resources